ZHONGHENG GROUP(600252)2024-10-22 08:43Group 1: Investor Relations and Market Confidence - The company emphasizes the importance of market value management through governance improvement, operational enhancement, and transparent information disclosure [2][3] - In 2024, the company repurchased a total of 122,928,437 shares, accounting for 3.5616% of the total share capital, with a total expenditure of RMB 279,110,029.03 [3] - The company distributed cash dividends of RMB 34,088,450.54 for the 2023 fiscal year, with a distribution ratio exceeding 35% [3] Group 2: Strategic Planning and Development - 2024 is a key year for the company to enhance economic performance and market expansion, focusing on high-quality development and governance improvement [3][4] - The company aims to become a leading enterprise in the cardiovascular field, enhancing its core competitiveness through a focus on pharmaceutical manufacturing and health consumption [4] - The company plans to extend its product line and enhance its market competitiveness by acquiring advantageous products through mergers and partnerships [4] Group 3: Product Innovation and Market Expansion - The company launched 14 innovative products in the health consumption sector in the first half of 2024, including bird's nest and black bean products [5] - In the personal care sector, the company developed 30 new SKUs in liquid cleaning products, aiming to expand brand influence and market penetration [5] - The company actively participates in rural revitalization strategies, introducing new products like "Double Money Black Bean Milk" to enhance product lines and brand operations [5]